Co-Authors
This is a "connection" page, showing publications co-authored by MICHELE REDELL and ERIC SCHAFER.
Connection Strength
0.222
-
Repurposing Atovaquone as a Therapeutic against Acute Myeloid Leukemia (AML): Combination with Conventional Chemotherapy Is Feasible and Well Tolerated. Cancers (Basel). 2023 Feb 20; 15(4).
Score: 0.222
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.